Article
Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
9 Nov 2021
Abstract excerpt
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global threat with an ever-increasing death toll even after a year on. Hence, the rapid identification of infected individuals with diagnostic tests continues to be crucial in the on-going effort to combat the spread of COVID-19. Viral nucleic acid detection via real-time reverse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
